topics

10/22/25

97. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of

nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM)

and American society for parenteral and enteral nutrition (ASPEN). JPEN J Parenter Enteral Nutr

2009;33:277–316.

98. National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical

Trials Network, Rice TW, Wheeler AP, et al. Initial trophic vs. full enteral feeding in patients with

acute lung injury: the EDEN randomized trial. JAMA. 2012; 307:795.

99. McClave SA, Lukan JK, Stefater JA, et al. Poor validity of residual volumes as a marker for risk of

aspiration in critically ill patients. Crit Care Med 2005;33(2):324–330.

100. Heyland DK, Novak F. Immunonutrition in the critically ill patients: more harm than good? JPEN J

Parenter Enteral Nutr 2001;25(2 Suppl):S51–S55; discussion S55–S56.

101. Luiking YC, Engelen MP, Deutz NE. Regulation of nitric oxide production in health and disease.

Curr Opin Clin Nutr Metab Care 2010;13:97–104.

102. Ho KM, Dobb GJ, Webb SA. A comparison of early gastric and post-pyloric feeding in critically ill

patients: a meta-analysis. Intens Care Med 2006;32:639–649.

103. Prelack K, Dylewski M, Sheridan RL. Practical guidelines for nutritional management of burn injury

and recovery. Burns 2007;33(1):14–24.

104. Burlew CC, Moore EE, Cuschieri J, et al. Who should we feed? Western Trauma Association multiinstitutional study of enteral nutrition in the open abdomen after injury. J Trauma Acute Care Surg

332

http://surgerybook.net/

2012;73(6):1380–1387.

105. Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition

support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr

2003;27(5):355–373.

106. Desai SV, McClave SA, Rice TD. Nutrition in the ICU: an evidence-based approach. Chest

2014;145(5):1148–1157.

107. Dhaliwal R, Heyland DK. Nutrition and infection in the intensive care unit: what does the evidence

show? Curr Opin Crit Care 2005;11(5):461–467.

108. Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and outcomes of critically ill patients treated

with vasopressors and mechanical ventilation. Am J Crit Care 2010;19(3):261–268.

109. Yang S, Wu X, Yu W, et al. Early enteral nutrition in critically ill patients with hemodynamic

instability: an evidence-based review and practical advice. Nutr Clin Pract 2014;20(1):90–96.

110. National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical

Trials Network, Rice TW, Wheeler AP, et al. Initial trophic vs. full enteral feeding in patients with

acute lung injury: the EDEN randomized trial. JAMA 2012;307(8):795–803.

111. Casaer MP, Mesotten D, Hermas G, et al. Early versus late parenteral nutrition in critically ill

adults. NEJM 2011;365:506–517.

112. Sena MJ, Utter GH, Cuschieri J, et al. Early supplemental parenteral nutrition is associated with

increased infectious complications in critically ill trauma patients. J Am Coll Surg 2008;207(4):459–

467.

113. Heidegger CP, Berger MM, Graf S, et al. Optimization of energy provision with supplemental

nutrition in critically ill patients: a randomized controlled clinical trial. Lancet 2013;381(9864):385–

393.

114. CALORIES Trial Investigators, Harvey SE, Parrott F, et al. Trial of the route of early nutritional

support in critically ill adults. N Engl J Med 2014; 371(18):1673–1684.

115. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants

in critically ill patients. N Engl J Med 2013; 368(16):1489–1497.

116. Palmer AJ, Ho CK, Ajibola O, et al. The role of omega 3 fatty acid supplemented parenteral

nutrition in critical illness in adults: a systemic review and meta-analysis. Crit Care Med

2013;41(1):307–316.

117. Manzanares W, Dhaliwal R, Juresitsch B, et al. Parenteral fish oil lipid emulsions in the critically

ill: a systemic review and meta-analysis. JPEN J Parenter Enteral Nutr 2014;38(1):20–28.

118. Van Zanten AR, Sztark F, Kaisers UX, et al. High-protein enteral nutrition with immune-modulating

nutrients vs. standard high-protein enteral nutrition and nosocomial infections in the ICU: a

randomized clinical trial. JAMA 2014;312(5):514–524.

119. Al-Omran M, Albalawi ZH, Tashkandi MF, et al. Enteral versus parenteral nutrition for acute

pancreatitis. Cochrane Database Syst Rev 2010;(1):CD002837.

120. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill

patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330(6):377.

121. Marik PE, Vasu T, Hirani A, et al. Stress ulcer prophylaxis in the new millennium: a systematic

review and meta-analysis. Crit Care Med 2010;38(11):2222–2228.

122. Leontiadis GI, Sharma VK, Howden CW. Systemic review and meta-analysis of proton pump

inhibitor therapy in peptic ulcer bleeding. BMJ 2005;330(7941):568.

123. Kasotakis G, Sideris A, Yang Y, et al. Aggressive early crystalloid resuscitation adversely affects

outcomes in adult blunt trauma patients: an analysis of the Glue Grant database. J Trauma Acute

Care Surg 2013;74(5):1215–1221.

124. Bellomo R, Ronco C, Kellum JA, et al. Acute Renal Failure – definition, outcome measures, animal

models, fluid therapy and information technology needs: the Second International Consensus

Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):R204–R212.

125. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to

improve outcomes in acute kidney injury. Crit Care 2007;11(2):R31.

126. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int Suppl 2012;2:8.

127. Au TH, Bruckner A, Mohiuddin SM, et al. The prevention of contrast-induced nephropathy. Ann

Pharmacother 2014;48(10):1332–1342.

333

http://surgerybook.net/

128. Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systemic

review. Ann Pharmacotherapy 2013;47(1):90–105.

129. Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose dopamine or low-dose nesiritide in acute heart

failure with renal dysfunction. The ROSE acute heart failure randomized trial. JAMA

2013;310(23):2533–2543.

130. Joannidis M, Drumli W, Forni LG. Prevention of acute kidney inury and protection of renal

function in the intensive care unit. Int Care Med 2010;36:392–411.

131. Wu MY, Chang NC, Su CL, et al. Loop diuretic strategies in patients with acute decompensated

heart failure: a meta-analysis of randomized controlled trials. J Crit Care 2014;29:2–9.

132. Ejaz AA, Mohandas R. Are diuretics harmful in the management of acute kidney injury? Curr Opin

Nephrol Hypertens 2014;23(2):155–160.

133. Algahtani F, Koulouridis I, Susantitaphong P, Dahal K, et al. A meta-analysis of continuous vs.

intermittent infusion of loop diuretics in hospitalized patients. J Crit Care 2014;29(1):10–17.

134. Palazzuoli A, Pellegrini M, Ruocco G, et al. Continuous versus bolus intermittent loop diuretic

infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care

2014;18(3):R134.

135. Finfer S, Cass A, Gallagher M, et al. The RENAL (Randomised Evaluation of Normal vs. Augmented

Level of Replacement Therapy) study: statistical analysis plan. Crit Care Resus;11(1):58–66.

136. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, et al. Intensity of renal

support in critically ill patients with acute kidney injury. N Engl J Med 2008;359(1):7–20.

137. Ricci Z, Ronco C. Timing, dose and mode of dialysis in acute kidney injury. Curr Opin Crit Care

2011;17:556–561.

138. Joannes-Boyau O, Honore PM, Perez P, et al. High-volume versus standard-volume hemofiltration

for septic shock patients with acute kidney injury (IVOIRE study): a multicenter randomized

controlled trial. Int Care Med 2013;39:1535–1546.

139. Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and

dialysis dependence after acute kidney injury: a systemic review and meta-analysis. Intensive Care

Med 2013;39:987–997.

140. Rauf AA, Long KH, Gajic O, et al. Intermittent hemodialysis versus continuous renal replacement

therapy for acute renal failure in the intensive care unit: an observational outcomes analysis. J

Intensive Care Med 2008;23(3):195–203.

141. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in

critically ill trauma patients. J Trauma 2005;58:921–924.

142. Jeremitsky E, Omert LA, Dunham CM, et al. The impact of hyperglycemia on patients with severe

brain injury. J Trauma 2005;58:47–50.

143. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a

heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471–1478.

144. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N

Engl J Med 2001;345:1359.

145. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-centre controlled trial

on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol

study. Intensive Care Med 2009;35(10):1738–1748.

146. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional

glucose control in critically ill patients. N Engl J Med 2009;360(13):1283–1297.

147. Egi M, Finfer S, Bellomo R. Glycemic control in the ICU. Chest 2011;140(1):212–220.

148. Burry LD, Wax RS. Role of corticosteroids in septic shock. Ann Pharmacother 2004;38(3):464–472.

149. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on

cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038–1045.

150. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and

fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862–871.

151. The CORTICUS Study Group, Sprung CL, Annane D, et al. Hydrocortisone therapy for patients with

septic shock. N Engl J Med 2008;358:111–124.

152. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and

334

http://surgerybook.net/

septic shock in adults: a systemic review. JAMA 2009;301(22):2362–2375.

153. Minneci PC, Deans KJ, Eichacker PQ, et al. The effects of steroids during sepsis depend on dos

Au TH, Bruckner A, Mohiuddin SM, et al. The prevention of contrast-induced nephropathy. Ann